Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

37.11 +0.31 (+0.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,878,483
Open 36.66
Bid (Size) 36.96 (7)
Ask (Size) 37.98 (1)
Prev. Close 36.80
Today's Range 36.37 - 37.22
52wk Range 24.05 - 37.56
Shares Outstanding 388,132,400
Dividend Yield 2.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Reasons to Watch RPRX and 1 to Stay Cautious
Royalty Pharma has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.3%. The stock now trades at $36.72, marking a 16.2% gain. This was partly thanks to its... 
Via StockStory
Topics Stocks
3 Profitable Stocks to Research Further
Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting... 
Via StockStory
Topics Supply Chain

Performance

YTD
+43.9%
+43.9%
1 Month
+2.1%
+2.1%
3 Month
+12.5%
+12.5%
6 Month
+18.4%
+18.4%
1 Year
+30.1%
+30.1%

More News

Read More
Royalty Pharma Declares Third Quarter 2025 Dividend
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
From Royalty Pharma plc
Via GlobeNewswire
A Look Into Royalty Pharma Inc's Price Over Earnings
Via Benzinga
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
From Royalty Pharma plc
Via GlobeNewswire
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
2 Surging Stocks to Research Further and 1 to Be Wary Of
Via StockStory
Revolution Medicines To Advance Lead Cancer Drug With $2 Billion In Funds
Via Benzinga
How Is The Market Feeling About Royalty Pharma?
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Revolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty Pharma
Via Stocktwits
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
From Royalty Pharma plc
Via GlobeNewswire
Q1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
RPRX Q1 Earnings Call: Flat Revenue, Portfolio Expansion, and Capital Return Initiatives
Via StockStory
2 Value Stocks to Target This Week and 1 to Turn Down
Via StockStory
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
From Royalty Pharma plc
Via GlobeNewswire
1 Stock Under $50 with Competitive Advantages and 2 to Question
Via StockStory
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Royalty Pharma Completes the Acquisition of Its External Manager
From Royalty Pharma plc
Via GlobeNewswire
3 of Wall Street’s Favorite Stocks with Mounting Challenges
Via StockStory
Royalty Pharma to Present at Upcoming Investor Conferences
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma (NASDAQ:RPRX) Posts Q1 Sales In Line With Estimates
Via StockStory
Royalty Pharma Reports First Quarter 2025 Results
From Royalty Pharma plc
Via GlobeNewswire

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 37.11
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 08/01/25 04:00 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 14.40B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.